Sponsor Pipeline

Uma Borate Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 2
3
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05641831 Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal… Clonal Cytopenia of Undetermined Significance Recruiting
NCT05379166 Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic… Secondary Myelodysplastic Syndrome Active, Not Recruiting
NCT06930352 Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute… Acute Myeloid Leukemia Not Yet Recruiting
Phase 1/2
NCT06523556 Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase… Atypical Chronic Myeloid Leukemia Recruiting
Phase 1
NCT06222580 SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute… Acute Myeloid Leukemia With FLT3/ITD Mutation Recruiting
Disease Areas
Leukemia (3) Myelodysplastic Syndromes (MDS) (2) Acute Myeloid Leukemia (AML) (2) Chronic Myeloid Leukemia (CML) (1) Myelofibrosis (1)
Get alerts when Uma Borate's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free